Outcomes of tyrosine kinase inhibitors (TKI) after immunotherapy in unresectable or advanced hepatocellular carcinoma (HCC) patients.

Yau, TC; Tang, V; Chan, J; Kwok, GW; Chiu, J; Leung, RCY; Li, B; Cheung, TT

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (4):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索